openPR Logo
Press release

Pulmonary Dilation Balloon Market Global Industry Analysis and Forecast Till 2027

11-15-2017 06:59 AM CET | Health & Medicine

Press release from: Future Market Insights

/ PR Agency: Future Market Insights
Pulmonary Dilation Balloon Market Global Industry Analysis

The pulmonary dilation balloon is a technique used in the treatment of pulmonary valve stenosis. Pulmonary valve stenosis is an abnormality in which there is some deformity on or in the vicinity of the pulmonary valve, and this abnormality slows the blood flow. The pulmonary valve is the valve that aids the blood flow from the heart to lungs. In most of the cases, pulmonary valve stenosis develops before the birth of the person. In adults, if present pulmonary valve stenosis is present as a complication of some other illness. Pulmonary valve stenosis can be treated by some other methods also, but pulmonary dilation balloon has emerged as the most favored option over the past few years.

Request For ToC @ https://www.futuremarketinsights.com/toc/rep-gb-3485

Pulmonary valve stenosis has emerged as a serious disease in the last few years. According to a report published on National Center for Biotechnology Information (NCBI) 7.5% - 9% diseases of all the congenital heart diseases is pulmonary valve stenosis. According to the data of CDC more than 40,000 children are born with congenital heart diseases in the U.S. alone. Other than this over 2million people in the U.S. are living with congenital heart diseases. This high prevalence of the disease illustrates the possibilities for the market of pulmonary dilation balloon.

Pulmonary Dilation Balloon Market: Drivers and Restraints

The major factors that are expected to drive the growth of the pulmonary dilation balloon market are an increase in the number of congenital heart diseases and early detection of the disease owing to the better medical facilities. Also, the minimally invasive method of pulmonary dilation balloon procedure is favoring its adoption over the conventional surgical methods. Pulmonary dilation balloon procedure also involves fewer complications and a success rate, thereby increasing the chances of market growth.

The major factors that can limit the growth of the pulmonary dilation balloon market are the complexity of the pulmonary valve stenosis in some patients that does not allow the use of pulmonary dilation balloon and demands surgical procedure.

Pulmonary Dilation Balloon Market: Overview

The market for pulmonary dilation balloon is expected to see higher growth in the forecast period due to the increase in the incidences of pulmonary valve stenosis in the past few years. The pulmonary dilation balloon is a procedure used to open up the blocked artery. The removal of the blockage helps in restoring the normal functionality of the artery and the valve, and thus pulmonary dilation balloon procedure is used in the treatment of pulmonary valve stenosis. The pulmonary dilation balloon is not as invasive as surgery, and this is one of the major reasons behind its success. But along with all these merits the major limitation that pulmonary dilation balloon procedure has, is the risk factors associated with the procedure in rare cases. But the long-term effects and the high success rate over powers the limitations of the pulmonary dilation balloon.

Pulmonary Dilation Balloon Market: Region-wise Outlook

North America and Europe are the most developed market in pulmonary dilation balloon due to the presence of the advanced healthcare infrastructure. Asia Pacific albeit has a higher number of pulmonary valve stenosis cases but the lack of awareness about pulmonary dilation balloon is responsible for the less usage of pulmonary dilation balloon in this region. Middle East and African countries are seeing an even less growth of the market due to lower GDP, but the growth is expected to increase worldwide due to high adoption rate.

Request For Report sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-3485

Pulmonary Dilation Balloon Market: Key Market Participants

The key players of the market include Boston Scientific and Envaste Medical Instruments.

About Us

Future Market Insights (FMI) is a leading market intelligence and consulting firm. We deliver syndicated research reports, custom research reports and consulting services, which are personalized in nature. FMI delivers a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights, an aerial view of the competitive framework, and future market trends.

Contact Us

Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
F: +1-845-579-5705
Email: sales@futuremarketinsights.com
Website: www.futuremarketinsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Pulmonary Dilation Balloon Market Global Industry Analysis and Forecast Till 2027 here

News-ID: 816953 • Views:

More Releases from Future Market Insights

Eye Health Ingredients Market to Reach USD 360.3 Million by 2035, Driven by 7.5% CAGR and Rising Demand for Carotenoids and Omega Compounds
Eye Health Ingredients Market to Reach USD 360.3 Million by 2035, Driven by 7.5% …
The global eye health ingredients industry is projected to reach USD 360.3 million by 2035, expanding from USD 174.8 million in 2025 at a CAGR of 7.5%. Growth is fueled by increasing consumer awareness around preventive eye health, heavy screen exposure, and rising age-related vision issues. As consumers adopt nutraceuticals, fortified foods, and ocular supplements, demand for carotenoids, omega-based compounds, and botanical extracts continues to scale across retail and healthcare
Global Grapeseed Oil Market Set for 4.1% CAGR, Expected to Hit USD 809.3 Million by 2035
Global Grapeseed Oil Market Set for 4.1% CAGR, Expected to Hit USD 809.3 Million …
The global grapeseed oil market is projected to grow from USD 541.5 million in 2025 to USD 809.3 million by 2035, registering a CAGR of 4.1%. Rising demand across culinary, personal care, and nutraceutical applications is elevating its market value due to its rich antioxidant profile, vitamin E content, and plant-based origin. Health-conscious consumers are increasingly choosing grapeseed oil for premium cooking and natural skincare, while manufacturers expand cold-pressing capacities to
Soybean Enzymatic Protein Market Set to Reach USD 5.2 Billion by 2035, Driven by 7.8% CAGR
Soybean Enzymatic Protein Market Set to Reach USD 5.2 Billion by 2035, Driven by …
The global soybean enzymatic protein market is moving into a phase of rapid commercial adoption, projected to expand from USD 2.4 billion in 2025 to USD 5.2 billion by 2035, registering a CAGR of 7.8%. What began as a niche application segment during 2020-2024 has now matured into a scalable, mainstream protein category integrated into beverages, functional foods, meat alternatives, and nutritional supplements. Between 2025 and 2030, the market enters its
Global Squid Market to Reach USD 18.4 Billion by 2035, Driven by 3.8% CAGR Growth
Global Squid Market to Reach USD 18.4 Billion by 2035, Driven by 3.8% CAGR Growt …
The global squid market, valued at USD 12.7 billion in 2025, is projected to reach USD 18.4 billion by 2035, reflecting a 3.8% CAGR, driven by rising seafood demand, diversified product formats, and robust food supply chains. Steady consumption growth across Asia-Pacific, Europe, and North America continues to uplift commercial fishing, aquaculture, and value-added squid processing. Growth momentum between 2021 and 2025 shows a consistent upward curve, with the market expanding

All 5 Releases


More Releases for Pulmonary

Innovation In Pulmonary Drug Delivery Devices Industry Trends Gaining Momentum i …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Pulmonary Drug Delivery Devices Market Size Valuation Forecast: What Will the Market Be Worth by 2025? The market size for pulmonary drug delivery devices has experienced significant growth in the past few years. The market is projected to increase from $49.52 billion in 2024 to $52.8 billion in 2025,
Chronic Pulmonary Aspergillosis Drugs Market - Revitalizing Lungs: Revolutionary …
Newark, New Castle, USA - new report, titled Chronic Pulmonary Aspergillosis Drugs Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Chronic Pulmonary Aspergillosis Drugs market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Chronic Pulmonary Aspergillosis Drugs market. The report offers
Global Pulmonary Arterial Hypertension Market Size
According to a new market research report published by Global Market Estimates, the Global Pulmonary Arterial Hypertension Market is projected to grow at a CAGR of 5.2% from 2022 to 2027. Congenital heart diseases and other ailments such as HIV infection, chronic liver disease (cirrhosis), and connective tissue disorders (scleroderma, lupus, and others) are fueling market expansion. Browse 153 Market Data Tables and 113 Figures spread through 185 Pages and in-depth TOC
New Study: Pulmonary Drugs Market Report
The pulmonary drugs market is expected to witness unprecedented growth in the near future, thanks to large number of approvals from the FDA. The FDA approved a large number of pulmonary drugs for major illnesses like small-cell lung cancer, tuberculosis, and pneumonia over the past few years. Additionally, newly approved drugs also treat newly found diseases like obstructive sleep apnea. These approvals are in line with the recent trend of
Pulmonary Drugs Market Forecast till 2025
Pulmonary Drugs Market – Boon for Diseased Lungs Pulmonary drugs can treat wide range of conditions, which are included within the ambit of pulmonary diseases such as pneumonia, allergic rhinitis, pulmonary hypertension, and others. . Pulmonary drugs provide medications for all types of pulmonary diseases, which is expected to fuel market growth in near future. The World Health Organization (WHO) states that most respiratory diseases are preventable and can be treated
03-15-2017 | Health & Medicine
TMR
Pulmonary Drug Delivery Devices Market: Demand for Pulmonary Drug Delivery Devic …
This report on pulmonary drug delivery devices studies the current as well as future prospects of the market globally. The stakeholders of this report include companies and intermediaries engaged in the manufacture and commercialization of various pulmonary/respiratory drugs and/or drug-device combinations as well as new entrants planning to enter this market. This report comprises an elaborate executive summary along with a market snapshot providing overall information of various segments and sub-segments